Company profile for Life Molecular Imaging

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Life Molecular Imaging (LMI) was founded in 2012 with the acquisition of the molecular imaging research and development portfolio of Bayer Pharma AG by Piramal and is now part of Life Healthcare’s Alliance Medical. Life Molecular Imaging is developing a product portfolio of innovative molecular imaging tracers that address major clinical needs in neurology and cardiology. Its research and development portfolio focuses on neu...
Life Molecular Imaging (LMI) was founded in 2012 with the acquisition of the molecular imaging research and development portfolio of Bayer Pharma AG by Piramal and is now part of Life Healthcare’s Alliance Medical. Life Molecular Imaging is developing a product portfolio of innovative molecular imaging tracers that address major clinical needs in neurology and cardiology. Its research and development portfolio focuses on neurodegenerative and cardiovascular diagnostics, including a next-generation Tau tracer for Alzheimer’s disease and progressive supranuclear palsy.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
First Floor, The Woods Opus 40 Business Park Warwick CV34 5AH
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/life-molecular-imaging-expands-neuraceq-florbetaben-f-18-injection-production-in-decatur-il-302576963.html

PR NEWSWIRE
07 Oct 2025

https://www.prnewswire.com/news-releases/life-molecular-imaging-expands-neuraceq-florbetaben-f-18-injection-production-in-southern-california-302534927.html

PR NEWSWIRE
20 Aug 2025

https://www.prnewswire.com/news-releases/fda-expands-indications-for-neuraceq-an-amyloid-pet-imaging-agent-to-enhance-diagnosis-and-care-of-patients-with-alzheimers-disease-302496154.html

PR NEWSWIRE
01 Jul 2025

https://www.prnewswire.com/news-releases/european-commission-grants-orphan-drug-designation-to-florbetaben-18f-for-diagnosis-of-attr-amyloidosis-302480425.html

PR NEWSWIRE
12 Jun 2025

https://www.prnewswire.com/news-releases/life-molecular-imaging-and-sofie-announce-neuraceq-availability-in-albany-ny-302460460.html

PR NEWSWIRE
20 May 2025

https://www.prnewswire.com/news-releases/life-molecular-imaging-secures-funding-from-the-alzheimers-drug-discovery-foundation-addf-to-further-investigate-18ff-ded-pet-in-alzheimers-neuroinflammation-302459645.html

PR NEWSWIRE
20 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty